[1]颜新生a,张 丹a,王 栋a,等.疑似肺炎患者BALF 样本应用tNGS 技术进行病原学诊断的价值研究[J].现代检验医学杂志,2023,38(05):12-16.[doi:10.3969/j.issn.1671-7414.2023.05.003]
 YAN Xinshenga,ZHANG Dana,WANG Donga,et al.Value of tNGS in the Etiological Diagnosis of BALF Samples from Suspected Pneumonia Patients[J].Journal of Modern Laboratory Medicine,2023,38(05):12-16.[doi:10.3969/j.issn.1671-7414.2023.05.003]
点击复制

疑似肺炎患者BALF 样本应用tNGS 技术进行病原学诊断的价值研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年05期
页码:
12-16
栏目:
论著
出版日期:
2023-09-15

文章信息/Info

Title:
Value of tNGS in the Etiological Diagnosis of BALF Samples from Suspected Pneumonia Patients
文章编号:
1671-7414(2023)05-012-05
作者:
颜新生a张 丹a王 栋a张李涛a张真路a连姝文b
(武汉亚心总医院 a. 检验科;b. 药学部,武汉 430056)
Author(s):
YAN Xinshenga ZHANG Dana WANG Donga ZHANG Litaoa ZHANG Zhenlua LIAN Shuwenb
(a.Department of Clinical Laboratory; b.Department of Pharmacy, Wuhan Asia General Hospital, Wuhan 430056, China)
关键词:
靶向高通量测序支气管肺泡灌洗液病原体检测
分类号:
R563.1;R446.5
DOI:
10.3969/j.issn.1671-7414.2023.05.003
文献标志码:
A
摘要:
目的 探究靶向高通量测序(targeted next-generation sequencing,tNGS)技术在疑似肺炎患者支气管肺泡灌洗液(bronchoalveolar lavage fluid,BALF)样本中的病原学诊断价值。方法 选取2022 年7 月~ 2023 年3 月武汉亚心总医院收治的102 例疑似肺炎患者的102 份BALF 样本,对其同时进行了tNGS 检测和传统微生物学检测,并收集患者的一般临床资料。对纳入研究的102 例患者的tNGS 检测结果、微生物培养结果以及其他实验室检查结果进行回顾性分析。结果 tNGS 法的总体阳性检出率(93.14%)高于传统方法(58.82%),差异有统计学意义(χ2=32.903,P< 0.001);tNGS 法在细菌、病毒以及混合感染方面的检出率(65.69%,55.89%,69.61%)高于传统方法(21.57%,6.86%,11.76%),差异有统计学意义(χ2=32.903,56.920,70.708,均P < 0.001)。结论 tNGS 技术在疑似肺炎患者BALF样本中获得了较高的病原体检出率,可以有效应用于呼吸道感染性疾病的病原学诊断。
Abstract:
Objective To explore the value of targeted next-generation sequencing (tNGS) in etiological diagnosis of bronchoalveolar lavage fluid (BALF) samples from patients with suspected pneumonia. Methods 102 samples of BALF samples from 102 suspected pneumonia patients admitted to Wuhan Asia General Hospital from July 2022 to March 2023 were selected. tNGS and traditional microbiology tests were performed on them at the same time, and general clinical data of the patients were collected. tNGS test results, microbial culture results and other laboratory results of 102 patients were retrospectively analyzed. Results The overall positive detection rate of tNGS method (93.14%) was higher than that of traditional method (58.82%), and the difference was statistically significant (χ2=32.903, P< 0.001). The detection rates of bacterial, viral and mixed infections by tNGS method (65.69%,55.89%, 69.61%) were higher than those by traditional methods (21.57%,6.86%,11.76%), and the differences were statistically significant (χ2=32.903,56.920,70.708,all P< 0.001). Conclusion tNGS technique has a high pathogen detection rate in BALF samples of suspected pneumonia patients, and can be effectively used in the etiological diagnosis of respiratory infectious diseases.

参考文献/References:

[1] GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease study 2016[J]. Lancet, 2017, 390(10100): 1151-1210.
[2] HAN Xiudi, LIU Xuedong, CHEN Liang, et al. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients[J]. BMC Infectious Diseases, 2020, 20(1): 668.
[3] WU Xiaodong, LI Yuanyuan, ZHANG Ming, et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing: a prospective multicenter study[J]. Infectious Diseases and Therapy, 2020, 9(4): 1003-1015.
[4] WANG Chuwen, YAN Danying, HUANG Jiajia, et al. The clinical application of metagenomic next-generation sequencing in infectious diseases at a tertiary hospital in China[J]. Frontiers in Cellular and Infection Microbiology, 2022, 12: 957073.
[5] DENG Wenhua, XU Huan, WU Yabin, et al. Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia[J].Frontiers in Cellular and Infection Microbiology, 2022, 12: 950531.
[6] DAI Yi, SHENG Kai, HU Lan. Diagnostic efficacy of targeted high-throughput sequencing for lower respiratory infection in preterm infants[J]. American Journal of Translational Research, 2022, 14(11): 8204-8214.
[7] DAVIDSON K R, HA D M, SCHWARZ M I, et al. Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases[J]. Journal of Thoracic Disease, 2020, 12(9): 4991-5019.
[8] HUANG Jie, JIANG Erlie, YANG Donglin, et al. Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions[J]. Infection and Drug Resistance, 2020, 13: 567-576.
[9] SHI Cuilin, HAN Peng, TANG Peijun, et al. Clinical metagenomic sequencing for diagnosis of pulmonary tuberculosis[J]. Journal of Infection, 2020, 81(4): 567-574.
[10] MIAO Qing, MA Yuyan, WANG Qingqing, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice[J]. Clinical Infectious Diseases, 2018, 67(suppl_ 2): S231-S240.
[11] NIELSEN M C, CLARNER P, PAROHA R, et al. Comparison of analytical sensitivity (limit of detection) of xpert MTB/RIF and xpert MTB/RIF ultra for non-sputum specimens[J]. Pathogens, 2023, 12(2): 157.
[12] MITCHELL S L, SIMNER P J. Next-generation sequencing in clinical microbiology: are we there yet?[J]. Clinics in Laboratory Medicine, 2019, 39(3): 405-418.
[13] LIN Pengcheng, CHEN Yi, SU Shanshan, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients[J]. BMC Infectious Diseases, 2022, 22(1): 416.
[14] PENG Jinmin, DU Bin, QIN Hanyu, et al. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients[J].Journal of Infection, 2021, 82(4): 22-27.
[15] ZHENG Yan, QIU Xiaojian, WANG Ting, et al. The diagnostic value of metagenomic next-generation sequencing in lower respiratory tract infection[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11: 694756.
[16] GRENINGER A L. The challenge of diagnostic metagenomics[J]. Expert Review of Molecular Diagnostics, 2018, 18(7): 605-615.
[17] 中华医学会检验医学分会. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识[J].中华检验医学杂志, 2020, 43( 12): 1181-1195. Chinese Society of Laboratory Medicine. Expert consensus on clinical standardized application of metagenomics next-generation sequencing for detection of pathogenic microorganisms [J]. Chinese Journal of Laboratory Medicine, 2020, 43(12): 1181-1195.
[18] LI Shiying, TONG Jin, LIU Yi, et al. Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detection[J]. Journal of Infection, 2022, 85(5): e127-e129.
[19] GASTON D C, MILLER H B, FISSEL J A, et al. Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens[J]. Journal of Clinical Microbiology, 2022, 60(7): e0052622.
[20] GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease study 2019[J]. Lancet, 2022, 400(10369): 2221-2248.
[21] 邸师红, 马倩, 代超, 等.重症监护病房脓毒血症患者病原学分布及死亡高危因素分析[J]. 现代检验医学杂志, 2020, 35( 3): 141-145. DI Shihong, MA Qian, DAI Chao, et al. Etiology distribution and risk factors of death in patients with severe sepsis in intensive care unit[J]. Journal of Modern Laboratory Medicine, 2020, 35(3): 141-145.

相似文献/References:

[1]周道银,吴 茅,许绍强,等.支气管肺泡灌洗液细胞形态学检验中国专家共识[J].现代检验医学杂志,2020,35(06):4.[doi:doi:10.3969/j.issn.1671-7414.2020.06.002]
 ZHOU Dao-yin,WU Mao,XU Shao-qiang,et al.Consensus of Chinese Experts on Morphological Examination of Bronchoalveolar Lavage Fluid Cells(2020)[J].Journal of Modern Laboratory Medicine,2020,35(05):4.[doi:doi:10.3969/j.issn.1671-7414.2020.06.002]
[2]君安医学细胞平台专家委员会.支气管肺泡灌洗液细胞形态学检验中国专家共识(2023)[J].现代检验医学杂志,2023,38(03):11.[doi:10.3969/j.issn.1671-7414.2023.03.003]
 Expert Committee of J.EDU Medical Cell Platform Soliciting Contributions.Consensus of Chinese Experts on Morphological Examination of Bronchoalveolar Lavage Fluid Cells ( 2023)[J].Journal of Modern Laboratory Medicine,2023,38(05):11.[doi:10.3969/j.issn.1671-7414.2023.03.003]
[3]罗世龙a,李志强b,李 翔a.肺癌患者支气管肺泡灌洗液中DAPL1 和MLH1 基因甲基化水平检测及其临床意义研究[J].现代检验医学杂志,2024,39(05):125.[doi:10.3969/j.issn.1671-7414.2024.05.023]
 LUO Shilonga,LI Zhiqiangb,LI Xianga.Detection and Clinical Significance of DAPL1 and MLH1 Gene Methylation in Bronchoalveolar Lavage Fluid of Lung Cancer Patients[J].Journal of Modern Laboratory Medicine,2024,39(05):125.[doi:10.3969/j.issn.1671-7414.2024.05.023]

备注/Memo

备注/Memo:
基金项目:武汉市卫生健康委员会青年项目(WX21Q29):利伐沙班血药浓度与高龄非瓣膜性房颤患者不良预后的关系研究。
作者简介:颜新生(1986-),男,硕士,副主任技师,研究方向:分子诊断学,E-mail:yanxinsheng@126.com。
通讯作者:连姝文(1985-),女,本科,主管药师,研究方向:合理用药,E-mail:lianshuwen@126.com。
更新日期/Last Update: 2023-09-15